AMPEL BioSolutions
Amrie Grammer is the Founder, President & Chief Scientific Officer at AMPEL BioSolutions. Amrie has managed AMPEL from 2013-present with $20M+ in revenue from 15+ Pharma. Previously, Amrie was an Acting Director of Scientific & Clinical Content for Pharmacological Clinical Interface Program at Artemis (eBroselow LLC). Amrie holds a Doctor of Philosophy (PhD), Immunology from UTSW Medical Center at Dallas.
AMPEL BioSolutions
Precision medicine company commercializing LDTs that predict disease status, molecular pathways and best drug options.